Population-based study of islet cell carcinoma

Annals of Surgical Oncology

Volumn 14, Issue 12, 2007, Pages 3492-3500

  Yao, James C ^a   Eisner, Milton P ^b   Leary, Colleen ^a   Dagohoy, Cecile ^a   Phan, Alexandria ^a   Rashid, Asif ^a   Hassan, Manal ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Islet cell; Neuroendocrine tumor; Pancreatic endocrine tumor; Survival

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DATA BASE; FEMALE; HISTOLOGY; HISTORY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PANCREAS; PANCREAS ISLET CELL CARCINOMA; POPULATION RESEARCH; POSTMARKETING SURVEILLANCE; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, ISLET CELL; CHILD; CHILD, PRESCHOOL; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INSULINOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; REGISTRIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; VIPOMA;

EID: 36348967668     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9566-6     Document Type: Article

References (20)

1. Lamberts S, Uitterlinden P, Verschoor L, van Dongen K, del Pozo E. Long term treatment of acromegaly with the somatosatin analogue SMS201-995. N Engl J Med 1985;313:1576-80
2. Debelenko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997;6:2285-90
3. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 1999;12:539-45
4. Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr 1999;158:284-7
5. Tan CC, Hall RI, Semeraro D, Irons RP, Freeman JG. Ampullary somatostatinoma associated with von Recklinghausen's neurofibromatosis presenting as obstructive jaundice. Eur J Surg Oncol 1996;22:298-301
6. Yoshida A, Hatanaka S, Ohi Y, Umekita Y, Yoshida H. von Recklinghausen's disease associated with somatostatin-rich duodenal carcinoid (somatostatinoma), medullary thyroid carcinoma and diffuse adrenal medullary hyperplasia. Acta Pathol Jpn 1991;41:847-56
7. Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A 2005;102:8573-8
8. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000;119:1087-95
9. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59
10. Lepage C, Rachet B, Coleman MP. Survival from malignant digestive endocrine tumors in England and wales: a population-based study. Gastroenterology 2007;132:899-904
11. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: SEER 17 Regs Nov 2005 sub (1973-2003), ed. released April 2006. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistic Branch, 2006. Available at: Available at: http://www.seer. cancer.gov. Accessed August 14, 2007
12. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401
13. Surveillance Research Program NCI. SEER*Stat software, version 6.2.4, 2006. Available at: http://www.seer.cancer.gov /seerstat/. Accessed August 14, 2007
14. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute, 2006
15. Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer 1992;69:2154-9
16. Solorzano CC, Lee JE, Pisters PW, et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001;130:1078-85
17. Kouvaraki MA, Ajani JA, Hoff P, et al. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol 2004;22:4762-71
18. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-23
19. Kouvaraki MA, Solorzano CC, Shapiro SE, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 2005;89:170-85
20. Eriksson B, Skogseid B, Lundqvist G, Wide L, Wilander E, Oberg K. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990;65:1883-90